{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:00:10Z","timestamp":1793916010529,"version":"4.8.0"},"reference-count":62,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T00:00:00Z","timestamp":1587600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T00:00:00Z","timestamp":1587600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s40620-020-00739-8","type":"journal-article","created":{"date-parts":[[2020,4,23]],"date-time":"2020-04-23T08:02:39Z","timestamp":1587628959000},"page":"1001-1008","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Atherogenic dyslipidemia and diabetic nephropathy"],"prefix":"10.1093","volume":"33","author":[{"given":"Giuseppina","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Piscitelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Giandalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Viazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pontremoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Fioretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"De Cosmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,4,23]]},"reference":[{"issue":"3S1","key":"739_CR1","doi-asserted-by":"crossref","first-page":"A7","DOI":"10.1053\/j.ajkd.2019.01.001","volume":"73","author":"R Saran","year":"2019","unstructured":"Saran R, Robinson B, Abbott KC et al (2019) US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis 73(3S1):A7\u2013A8","journal-title":"Am J Kidney Dis"},{"key":"739_CR2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.semnephrol.2007.01.012","volume":"27","author":"P Fioretto","year":"2007","unstructured":"Fioretto P, Mauer M (2007) Histopathology of diabetic nephropathy. Semin Nephrol 27:195\u2013207","journal-title":"Semin Nephrol"},{"issue":"9731","key":"739_CR3","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","volume":"375","author":"K Matsushita","year":"2010","unstructured":"Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M et al (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375(9731):2073\u20132081","journal-title":"Lancet"},{"issue":"1","key":"739_CR4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/dc13-2112","volume":"37","author":"Nathan DM; DCCT\/EDIC Research Group","year":"2014","unstructured":"Nathan DM; DCCT\/EDIC Research Group (2014) The diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care 37(1):9\u201316","journal-title":"Diabetes Care"},{"issue":"9131","key":"739_CR5","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","unstructured":"UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352(9131):837\u2013853","journal-title":"Lancet"},{"issue":"24","key":"739_CR6","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","volume":"358","author":"HC Gerstein","year":"2008","unstructured":"Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME et al (2008) Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358(24):2545\u20132559","journal-title":"N Engl J Med"},{"issue":"24","key":"739_CR7","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","volume":"358","author":"A Patel","year":"2008","unstructured":"ADVANCE Collaborative Group, Patel A, MacMahon S et al (2008) Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358(24):2560\u20132572","journal-title":"N Engl J Med"},{"issue":"2","key":"739_CR8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","volume":"360","author":"W Duckworth","year":"2009","unstructured":"Duckworth W, Abraira C, Moritz T et al (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360(2):129\u2013139","journal-title":"N Engl J Med"},{"issue":"2\u20133","key":"739_CR9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1900\/RDS.2013.10.88","volume":"10","author":"SC Chen","year":"2013","unstructured":"Chen SC, Tseng CH (2013) Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients. Rev Diabet Stud 10(2\u20133):88\u2013100","journal-title":"Rev Diabet Stud"},{"issue":"2","key":"739_CR10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2337\/diacare.29.02.06.dc05-0809","volume":"29","author":"MC Thomas","year":"2006","unstructured":"Thomas MC, Roseng\u00e5rd-B\u00e4rlund M, Mills V et al (2006) Serum lipids and the progression of nephropathy in type 1 diabetes. Diabetes Care 29(2):317\u2013322","journal-title":"Diabetes Care"},{"issue":"1","key":"739_CR11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrendo.2009.213","volume":"6","author":"P Fioretto","year":"2010","unstructured":"Fioretto P, Dodson PM, Ziegler D et al (2010) Residual microvascular risk in diabetes: unmet needs and future directions. Nat Rev Endocrinol 6(1):19\u201325","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"739_CR12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1523-1755.2000.00165.x","volume":"58","author":"P Muntner","year":"2000","unstructured":"Muntner P, Coresh J, Smith JC et al (2000) Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney Int 58(1):293\u2013301","journal-title":"Kidney Int"},{"issue":"6","key":"739_CR13","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2337\/db05-1620","volume":"55","author":"R Retnakaran","year":"2006","unstructured":"Retnakaran R, Cull CA, Thorne KI et al (2006) Risk factors for renal dysfunction in type 2 diabetes: UK Prospective Diabetes Study 74. Diabetes 55(6):1832\u20131839","journal-title":"Diabetes"},{"issue":"3","key":"739_CR14","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1523-1755.2004.00869.x","volume":"66","author":"M Cusick","year":"2004","unstructured":"Cusick M, Chew EY, Hoogwerf B et al (2004) Risk factors for renal replacement therapy in the Early Treatment Diabetic Retinopathy Study (ETDRS), Early Treatment Diabetic Retinopathy Study Report No. 26. Kidney Int 66(3):1173\u20131179","journal-title":"Kidney Int"},{"issue":"11","key":"739_CR15","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.2337\/dc12-0306","volume":"35","author":"J Morton","year":"2012","unstructured":"Morton J, Zoungas S, Li Q et al (2012) Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy: results of the ADVANCE study. Diabetes Care 35(11):2201\u20132206","journal-title":"Diabetes Care"},{"issue":"9","key":"739_CR16","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/CIRCULATIONAHA.113.002529","volume":"129","author":"FM Sacks","year":"2014","unstructured":"Sacks FM, Hermans MP, Fioretto P et al (2014) Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries. Circulation 129(9):999\u20131008","journal-title":"Circulation"},{"issue":"6","key":"739_CR17","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1053\/j.ajkd.2015.05.011","volume":"66","author":"K Tsuruya","year":"2015","unstructured":"Tsuruya K, Yoshida H, Nagata M et al (2015) Impact of the triglycerides to high-density lipoprotein cholesterol ratio on the incidence and progression of CKD: a longitudinal study in a large Japanese population. Am J Kidney Dis 66(6):972\u2013983","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"739_CR18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.metabol.2011.05.004","volume":"61","author":"G Zoppini","year":"2012","unstructured":"Zoppini G, Negri C, Stoico V et al (2012) Triglyceride-high-density lipoprotein cholesterol is associated with microvascular complications in type 2 diabetes mellitus. Metabolism 61(1):22\u201329","journal-title":"Metabolism"},{"issue":"12","key":"739_CR19","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.2337\/dc16-1246","volume":"39","author":"GT Russo","year":"2016","unstructured":"Russo GT, De Cosmo S, Viazzi F et al (2016) Plasma triglycerides and HDL-C levels predict the development of diabetic kidney disease in subjects with type 2 diabetes: the AMD annals initiative. Diabetes Care 39(12):2278\u20132287","journal-title":"Diabetes Care"},{"issue":"5","key":"739_CR20","doi-asserted-by":"crossref","first-page":"e0125512","DOI":"10.1371\/journal.pone.0125512","volume":"10","author":"G Penno","year":"2015","unstructured":"Penno G, Solini A, Zoppini G et al (2015) Hypertriglyceridemia Is independently associated with renal, but not retinal complications in subjects with type 2 diabetes: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study. PLoS ONE 10(5):e0125512","journal-title":"PLoS ONE"},{"issue":"2","key":"739_CR21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/archinternmed.2009.471","volume":"170","author":"ST Tu","year":"2010","unstructured":"Tu ST, Chang SJ, Chen JF et al (2010) Prevention of diabetic nephropathy by tight target control in an asian population with type 2 diabetes mellitus: a 4-year prospective analysis. Arch Intern Med 170(2):155\u2013161","journal-title":"Arch Intern Med"},{"issue":"3","key":"739_CR22","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/j.ajkd.2007.11.010","volume":"51","author":"J Xu","year":"2008","unstructured":"Xu J, Lee ET, Devereux RB et al (2008) A longitudinal study of risk factors for incident albuminuria in diabetic American Indians: the Strong Heart Study. Am J Kidney Dis 51(3):415\u2013424","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"739_CR23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00125-009-1597-z","volume":"53","author":"J Lin","year":"2010","unstructured":"Lin J, Hu FB, Mantzoros C et al (2010) Lipid and inflammatory biomarkers and kidney function decline in type 2 diabetes. Diabetologia 53(2):263\u2013267","journal-title":"Diabetologia"},{"issue":"9500","key":"739_CR24","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","volume":"366","author":"A Keech","year":"2005","unstructured":"Keech A, Simes RJ, Barter P et al (2005) Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 366(9500):1849\u20131861","journal-title":"Lancet"},{"issue":"17","key":"739_CR25","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","volume":"362","author":"HN Ginsberg","year":"2010","unstructured":"ACCORD Study Group, Ginsberg HN, Elam MB et al (2010) Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 362(17):1563\u20131574","journal-title":"N Engl J Med"},{"issue":"2","key":"739_CR26","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s00125-010-1951-1","volume":"54","author":"TM Davis","year":"2011","unstructured":"Davis TM, Ting R, Best JD et al (2011) Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study. Diabetologia 54(2):280\u2013290","journal-title":"Diabetologia"},{"issue":"2","key":"739_CR27","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s10157-013-0880-y","volume":"18","author":"T Hirano","year":"2014","unstructured":"Hirano T (2014) Abnormal lipoprotein metabolism in diabetic nephropathy. Clin Exp Nephrol 18(2):206\u2013209","journal-title":"Clin Exp Nephrol"},{"issue":"1","key":"739_CR28","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.atherosclerosis.2007.03.015","volume":"197","author":"T Hayashi","year":"2008","unstructured":"Hayashi T, Hirano T, Taira T et al (2008) Remarkable increase of apolipoprotein B48 level in diabetic patients with end-stage renal disease. Atherosclerosis 197(1):154\u2013158","journal-title":"Atherosclerosis"},{"issue":"1","key":"739_CR29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0021-9150(01)00409-9","volume":"158","author":"GT Russo","year":"2001","unstructured":"Russo GT, Meigs JB, Cupples LA et al (2001) Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study. Atherosclerosis 158(1):173\u2013181","journal-title":"Atherosclerosis"},{"key":"739_CR30","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1172\/JCI127308","volume":"130","author":"JE Kanter","year":"2019","unstructured":"Kanter JE, Shao B, Kramer F et al (2019) Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes. J Clin Invest 130:4165\u20134179","journal-title":"J Clin Invest"},{"issue":"6","key":"739_CR31","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1046\/j.1523-1755.2003.00019.x","volume":"63","author":"T Hirano","year":"2003","unstructured":"Hirano T, Sakaue T, Misaki A et al (2003) Very low-density lipoprotein-apoprotein CI is increased in diabetic nephropathy: comparison with apoprotein CIII. Kidney Int 63(6):2171\u20132177","journal-title":"Kidney Int"},{"issue":"12","key":"739_CR32","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.metabol.2007.07.016","volume":"56","author":"Y Mori","year":"2007","unstructured":"Mori Y, Hirano T, Nagashima M et al (2007) Decreased peroxisome proliferator-activated receptor alpha gene expression is associated with dyslipidemia in a rat model of chronic renal failure. Metabolism 56(12):1714\u20131718","journal-title":"Metabolism"},{"issue":"4","key":"739_CR33","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.metabol.2006.11.002","volume":"56","author":"T Hirano","year":"2007","unstructured":"Hirano T, Hayashi T, Adachi M et al (2007) Marked decrease of apolipoprotein A-V in both diabetic and nondiabetic patients with end-stage renal disease. Metabolism 56(4):462\u2013463","journal-title":"Metabolism"},{"issue":"2","key":"739_CR34","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1194\/jlr.R039297","volume":"55","author":"KA Rye","year":"2014","unstructured":"Rye KA, Barter PJ (2014) Cardioprotective functions of HDLs. J Lipid Res 55(2):168\u2013179","journal-title":"J Lipid Res"},{"issue":"1","key":"739_CR35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.atherosclerosis.2005.10.018","volume":"188","author":"BF Asztalos","year":"2006","unstructured":"Asztalos BF, Demissie S, Cupples LA et al (2006) LpA-I, LpA-I:A-II HDL and CHD-risk: The Framingham Offspring Study and the Veterans Affairs HDL Intervention Trial. Atherosclerosis 188(1):59\u201367","journal-title":"Atherosclerosis"},{"issue":"1","key":"739_CR36","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.atherosclerosis.2009.11.011","volume":"210","author":"GT Russo","year":"2010","unstructured":"Russo GT, Horvath KV, Di Benedetto A et al (2010) Influence of menopause and cholesteryl ester transfer protein (CETP) TaqIB polymorphism on lipid profile and HDL subpopulations distribution in women with and without type 2 diabetes. Atherosclerosis 210(1):294\u2013301","journal-title":"Atherosclerosis"},{"issue":"3","key":"739_CR37","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/ndt\/gfm631","volume":"23","author":"H Zhou","year":"2008","unstructured":"Zhou H, Tan KC, Shiu SW et al (2008) Increased serum advanced glycation end products are associated with impairment in HDL antioxidative capacity in diabetic nephropathy. Nephrol Dial Transplant 23(3):927\u2013933","journal-title":"Nephrol Dial Transplant"},{"key":"739_CR38","doi-asserted-by":"crossref","first-page":"607924","DOI":"10.1155\/2014\/607924","volume":"2014","author":"GT Russo","year":"2014","unstructured":"Russo GT, Giandalia A, Romeo EL et al (2014) Markers of systemic inflammation and Apo-AI containing HDL subpopulations in women with and without diabetes. Int J Endocrinol 2014:607924","journal-title":"Int J Endocrinol"},{"issue":"3","key":"739_CR39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40618-013-0023-z","volume":"37","author":"GT Russo","year":"2014","unstructured":"Russo GT, Giandalia A, Romeo EL et al (2014) Lipid and non-lipid cardiovascular risk factors in postmenopausal type 2 diabetic women with and without coronary heart disease. J Endocrinol Invest 37(3):261\u2013268","journal-title":"J Endocrinol Invest"},{"key":"739_CR40","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.diabres.2017.07.026","volume":"132","author":"GT Russo","year":"2017","unstructured":"Russo GT, Giandalia A, Romeo EL et al (2017) HDL subclasses and the common CETP TaqIB variant predict the incidence of microangiopatic complications in type 2 diabetic women 9 years follow-up study. Diabetes Res Clin Pract 132:108\u2013117","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"739_CR41","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s40620-016-0278-5","volume":"29","author":"A Izquierdo-Lahuerta","year":"2016","unstructured":"Izquierdo-Lahuerta A, Mart\u00ednez-Garc\u00eda C, Medina-G\u00f3mez G (2016) Lipotoxicity as a trigger factor of renal disease. J Nephrol 29(5):603\u2013610","journal-title":"J Nephrol"},{"issue":"4","key":"739_CR42","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/ki.1993.129","volume":"43","author":"T Takemura","year":"1993","unstructured":"Takemura T, Yoshioka K, Aya N et al (1993) Apolipoproteins and lipoprotein receptors in glomeruli in human kidney diseases. Kidney Int 43(4):918\u2013927","journal-title":"Kidney Int"},{"issue":"1","key":"739_CR43","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0272-6386(12)70171-3","volume":"22","author":"D Schlondorff","year":"1993","unstructured":"Schlondorff D (1993) Cellular mechanisms of lipid injury in the glomerulus. Am J Kidney Dis 22(1):72\u201382","journal-title":"Am J Kidney Dis"},{"issue":"21","key":"739_CR44","doi-asserted-by":"crossref","first-page":"18919","DOI":"10.1074\/jbc.M110650200","volume":"277","author":"L Sun","year":"2002","unstructured":"Sun L, Halaihel N, Zhang W et al (2002) Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus. J Biol Chem 277(21):18919\u201318927","journal-title":"J Biol Chem"},{"issue":"6","key":"739_CR45","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1046\/j.1523-1755.2001.00071.x","volume":"60","author":"RA Zager","year":"2001","unstructured":"Zager RA, Johnson A (2001) Renal cortical cholesterol accumulation is an integral component of the systemic stress response. Kidney Int 60(6):2299\u20132310","journal-title":"Kidney Int"},{"issue":"9","key":"739_CR46","doi-asserted-by":"crossref","first-page":"e105787","DOI":"10.1371\/journal.pone.0105787","volume":"9","author":"JG Tsun","year":"2014","unstructured":"Tsun JG, Yung S, Chau MK et al (2014) Cellular cholesterol transport proteins in diabetic nephropathy. PLoS ONE 9(9):e105787","journal-title":"PLoS ONE"},{"issue":"12","key":"739_CR47","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s11892-019-1263-x","volume":"19","author":"GM Ducasa","year":"2019","unstructured":"Ducasa GM, Mitrofanova A, Fornoni A (2019) Crosstalk between lipids and mitochondria in diabetic kidney disease. Curr Diab Rep 19(12):144","journal-title":"Curr Diab Rep"},{"issue":"8","key":"739_CR48","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1007\/s00125-012-2578-1","volume":"55","author":"T Kuwabara","year":"2012","unstructured":"Kuwabara T, Mori K, Mukoyama M et al (2012) Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice. Diabetologia 55(8):2256\u20132266","journal-title":"Diabetologia"},{"issue":"4","key":"739_CR49","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s10157-013-0922-5","volume":"18","author":"T Kuwabara","year":"2014","unstructured":"Kuwabara T, Mori K, Mukoyama M et al (2014) Macrophage-mediated glucolipotoxicity via myeloid-related protein 8\/toll-like receptor 4 signaling in diabetic nephropathy. Clin Exp Nephrol 18(4):584\u2013592","journal-title":"Clin Exp Nephrol"},{"issue":"8","key":"739_CR50","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.2337\/diabetes.54.8.2328","volume":"54","author":"Z Wang","year":"2005","unstructured":"Wang Z, Jiang T, Li J, Proctor G et al (2005) Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb\/db mice with type 2 diabetes. Diabetes 54(8):2328\u20132335","journal-title":"Diabetes"},{"issue":"11","key":"739_CR51","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.2337\/db13-0399","volume":"62","author":"S Merscher-Gomez","year":"2013","unstructured":"Merscher-Gomez S, Guzman J, Pedigo CE et al (2013) Cyclodextrin protects podocytes in diabetic kidney disease. Diabetes 62(11):3817\u20133827","journal-title":"Diabetes"},{"issue":"12","key":"739_CR52","doi-asserted-by":"crossref","first-page":"E1140","DOI":"10.1152\/ajpendo.00591.2014","volume":"308","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Ma KL, Liu J et al (2015) Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy. Am J Physiol Endocrinol Metab 308(12):E1140\u20131148","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"739_CR53","first-page":"S18","volume":"54","author":"HJ Gr\u00f6ne","year":"1996","unstructured":"Gr\u00f6ne HJ, Hohbach J, Gr\u00f6ne EF (1996) Modulation of glomerular sclerosis and interstitial fibrosis by native and modified lipoproteins. Kidney Int Suppl 54:S18\u201322","journal-title":"Kidney Int Suppl"},{"issue":"8311","key":"739_CR54","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(82)91513-6","volume":"2","author":"JF Moorhead","year":"1982","unstructured":"Moorhead JF, Chan MK, El-Nahas M et al (1982) Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 2(8311):1309\u20131311","journal-title":"Lancet"},{"key":"739_CR55","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1046\/j.1523-1755.1999.07109.x","volume":"71","author":"K Jandeleit-Dahm","year":"1999","unstructured":"Jandeleit-Dahm K, Cao Z, Cox AJ et al (1999) Role of hyperlipidemia in progressive renal disease: focus on diabetic nephropathy. Kidney Int Suppl 71:S31\u201336","journal-title":"Kidney Int Suppl"},{"issue":"1","key":"739_CR56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ndt\/gfs290","volume":"28","author":"S De Cosmo","year":"2013","unstructured":"De Cosmo S, Menzaghi C, Prudente S et al (2013) Role of insulin resistance in kidney dysfunction: insights into the mechanism and epidemiological evidence. Nephrol Dial Transplant 28(1):29\u201336","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"739_CR57","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/MNH.0b013e32832f7002","volume":"18","author":"A Jauregui","year":"2009","unstructured":"Jauregui A, Mintz DH, Mundel P et al (2009) Role of altered insulin signaling pathways in the pathogenesis of podocyte malfunction and microalbuminuria. Curr Opin Nephrol Hypertens 18(6):539\u2013545","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"2","key":"739_CR58","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.diabres.2010.11.005","volume":"91","author":"JW Son","year":"2011","unstructured":"Son JW, Jang EH, Kim MK et al (2011) Diabetic retinopathy is associated with subclinical atherosclerosis in newly diagnosed type 2 diabetes mellitus. Diabetes Res Clin Pract 91(2):253\u2013259","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"739_CR59","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2337\/dc06-2558","volume":"30","author":"A Avogaro","year":"2007","unstructured":"Avogaro A, Giorda C, Maggini M et al (2007) Incidence of coronary heart disease in type 2 diabetic men and women: impact of microvascular complications, treatment, and geographic location. Diabetes Care 30(5):1241\u20131247","journal-title":"Diabetes Care"},{"issue":"7","key":"739_CR60","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S2213-8587(16)30057-2","volume":"4","author":"JR Brownrigg","year":"2016","unstructured":"Brownrigg JR, Hughes CO, Burleigh D et al (2016) Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study. Lancet Diabetes Endocrinol 4(7):588\u2013597","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"Suppl 1","key":"739_CR61","first-page":"S94","volume":"26","author":"ME Molitch","year":"2003","unstructured":"Molitch ME, DeFronzo RA, Franz MJ et al (2003) Diabetic nephropathy. Diabetes Care 26(Suppl 1):S94\u201398","journal-title":"Diabetes Care"},{"issue":"9","key":"739_CR62","doi-asserted-by":"crossref","first-page":"771","DOI":"10.5551\/jat.RV17023","volume":"25","author":"T Hirano","year":"2018","unstructured":"Hirano T (2018) Pathophysiology of diabetic dyslipidemia. J Atheroscler Thromb 25(9):771\u2013782","journal-title":"J Atheroscler Thromb"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-020-00739-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-020-00739-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-020-00739-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:56:24Z","timestamp":1777564584000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/33\/5\/1001\/8328433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,23]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["739"],"URL":"https:\/\/doi.org\/10.1007\/s40620-020-00739-8","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,23]]},"assertion":[{"value":"23 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}